Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Accumulating physical activity in at least 10-minute bouts predicts better lung function after 3-years in adults with cystic fibrosis

Narelle S. Cox, Jennifer A. Alison, Brenda M. Button, John W. Wilson, Judith M. Morton, Anne E. Holland
ERJ Open Research 2018 4: 00095-2017; DOI: 10.1183/23120541.00095-2017
Narelle S. Cox
1Discipline of Physiotherapy, La Trobe University, Melbourne, Australia
2Institute for Breathing and Sleep, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: n.cox@latrobe.edu.au
Jennifer A. Alison
3Discipline of Physiotherapy, Faculty of Health Sciences, University of Sydney, Sydney, Australia
4Dept of Physiotherapy, Royal Prince Alfred Hospital, Camperdown, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda M. Button
5Dept of Physiotherapy, Alfred Hospital, Melbourne, Australia
6Dept of Medicine, Alfred Campus, Monash University, Melbourne, Australia
7Dept of Respiratory Medicine, Alfred Hospital, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John W. Wilson
6Dept of Medicine, Alfred Campus, Monash University, Melbourne, Australia
7Dept of Respiratory Medicine, Alfred Hospital, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith M. Morton
8Dept of Respiratory Medicine, Monash Health, Clayton, Australia
9Dept of Medicine, Monash Campus, Monash University, Clayton, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne E. Holland
1Discipline of Physiotherapy, La Trobe University, Melbourne, Australia
2Institute for Breathing and Sleep, Melbourne, Australia
5Dept of Physiotherapy, Alfred Hospital, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne E. Holland
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Achieving physical activity guidelines by undertaking multiple bouts of moderate-vigorous physical activity ≥10 min duration, but not shorter periods of activity, was independently associated with less decline in FEV1 over 3 years among adults with CF http://ow.ly/yk6930ivCV8

To the Editor:

In people with cystic fibrosis (CF) reduced fitness and lower levels of physical activity have been associated with poorer prognosis [1] and greater decline in lung function [2]. Despite the health benefits of being physically active [3], in people with CF adherence to exercise programmes is often poor [4], and prescribed exercise training programmes have seldom translated into increased daily physical activity [5].

We have previously shown that while adults with CF frequently achieve a total of 30 min of moderate-vigorous physical activity (MVPA) each day, in keeping with physical activity guidelines [6], time spent in MVPA was predominantly accumulated in short duration sequences [7]. For physical activity to result in improvements to cardiorespiratory fitness it needs to be performed in a single concerted effort of 30-min duration or in multiple bouts of activity to total 30 min in a day, where a bout must be at least 10 min in duration [6, 8]. Whether the pattern of physical activity participation, as opposed to the total volume of activity, is important to long-term clinical outcomes in people with CF has not been reported using objective measures. We sought to explore the relationship between objectively measured patterns of physical activity participation and markers of disease progression, namely lung function and need for hospitalisation, during a 3-year follow-up period in adults with CF.

Data were collected from adults with stable CF aged >18 years participating in a prospective, observational study conducted at two centres in Melbourne, Australia. All participants provided written, informed consent. A full description of the methods is published elsewhere [7]. In brief, physical activity was measured objectively (over 7 days) using the SenseWear Armband (SWA, Bodymedia, Pittsburgh, PA, USA) in adults with CF who were not experiencing a respiratory exacerbation. For this follow-up analysis, 3-year outcome data relating to survival, lung function and hospitalisation, for the same cohort of patients, was collected from the patient medical record. Lung function tests undertaken within an 8-week period either side of a participant's 3-year anniversary of study enrolment were eligible for inclusion in this analysis. The original study, and follow-up data collection, was approved by the relevant Human Research Ethics Committees (Alfred Health project 375/10 and Monash Health project 10347A).

Statistical analyses were conducted using IBM SPSS statistics (Version 24.0; IBM Corp., Armonk, NY, USA). We assessed if the pattern of physical activity could predict clinical outcomes over 3-years with stepwise multiple linear regression analysis using annual rate of change in lung function (forced expiratory volume in 1 s (FEV1)) and respiratory exacerbations requiring hospitalisation (none, 1–2 or >2) [9] as dependent variables. Predictor variables were pattern of physical activity categorised as attainment, or not, of: 1) 30 min of MVPA accumulated throughout the course of the day (≥30MVPA or <30MVPA, respectively); or 2) 30 min of MVPA per day accumulated in bouts of at least 10 min in duration (MVPA-Bouts or MVPA-No Bouts, respectively), as well as total daily MVPA time (in minutes). Other predictor variables known to influence long-term outcomes in CF [9] were also included. Alpha was set at 0.05.

At baseline, 65 adults (34 male) with stable CF, mean±sd age 28±7 years and mean±sd FEV1 68±20% predicted were recruited, with 61 individuals having valid physical activity data for inclusion in the original analysis. At 3-year follow-up spirometry data were available for n=56 (86%) (no lung function n=6; died n=2; lung transplant n=1), resulting in 53 complete cases (baseline valid physical activity and 3-year follow-up spirometry) for inclusion (table 1). At 3-year follow-up mean±sd FEV1 was 65±24% predicted, while median respiratory-related hospital admissions and hospital days were 2 (interquartile range (IQR): 1–7) and 28 (IQR: 9–107), respectively. Mean±sd change in FEV1 from baseline to 3-year follow-up was −0.11±0.33 L.

View this table:
  • View inline
  • View popup
TABLE 1

Demographic details and clinical outcomes relative to physical activity performance

In a stepwise multiple linear regression model that included age, sex, body mass index, baseline FEV1, CF-related diabetes and pancreatic insufficiency, the only significant predictors of annual rate of change in FEV1 were age (β=−0.006, se of β=0.002, p=0.027) and MVPA-Bouts (β=0.081, se of β=0.033, p=0.018). This model explained 32% of the variation in change in FEV1 (F (1, 42)=6.12, p=0.018), of which 13% was attributable to MVPA-Bouts. When regression analysis was repeated using alternate patterns of physical activity (≥30MVPA or total MVPA time per day, rather than MVPA-Bouts) the model was no longer significant (p=0.16 and p=0.07, respectively). Pattern of physical activity accumulation was not an independent contributor to the model predicting exacerbations requiring hospitalisation at 3-year follow-up.

The analysis reported here indicates that accumulating 30 min of MVPA a day in bouts of at least 10-minutes duration is a significant independent predictor of less decline in lung function over 3-years in adults with CF. This would suggest that concerted efforts of moderately intense physical activity in bouts of purposeful exercise, such as brisk walking at speeds above 4.8 km per hour or cycling at more than 8 km per hour [10], are necessary to achieve better outcomes in clinically relevant measures (specifically FEV1) in adults with CF, as opposed to only accumulating incidental physical activity through daily living. In our cohort, relatively few adults with CF were able to achieve 30 min of MVPA a day in bouts of at least 10-minutes duration. Whether failure to achieve 30 min of MVPA a day in bouts relates to physiological limitations, attitudes and behaviour relating to physical activity or time constraints imposed by other therapy requirements is not clear.

Very few studies have reported on the long-term relationship between physical activity and clinical outcomes, in particular lung function, in people with CF. Collaco et al. [11], using US CF Foundation patient registry data, found adults who self-reported any exercise participation had a slower rate of decline in FEV1 over 5 years. In a predominantly paediatric cohort, participants who were categorised as having higher levels of activity, based on self-report using the Habitual Activity Estimation Scale, had a slower rate of decline in FEV1 over an average of 5-years of follow-up [2]. However, the nature, duration and intensity of exercise were not elucidated in these studies. By using the SenseWear Armband, a valid, objective measure of physical activity in adults with CF [12], we have described the pattern, not just volume, of physical activity associated with less decline in lung function over time. Such objective measures of physical activity provide composite information in terms of activity frequency, intensity and duration [13], and are able to overcome issues of bias due to memory recall that are associated with subjective measures of physical activity [14]. Despite this, objective measurement of physical activity remains subject to variations imposed by external factors such as weather or daylight hours. Although assessed over a multi-day period as recommended [15], the effect of changes in health, personal circumstances or season on physical activity in this cohort could not be controlled.

In the present analysis we found pattern of physical activity did not predict need for hospitalisation due to respiratory exacerbation over the 3-year follow-up. This is in keeping with the findings of Savi et al. [9] who found no association between the number of pulmonary exacerbations in the preceding year and physical activity variables when corrected for clinical covariates. In our previous 1-year follow-up analysis we noted that, compared to those who did not, individuals who achieved physical activity recommendations in bouts of at least 10-min duration had significantly fewer hospital days and a trend towards fewer hospital admissions over 12-months [7]; however, physical activity was not an independent predictor of hospital time when controlling for other clinical variables. This serves to highlight the intricate interaction between changes in health status as a consequence of a progressive disease and the complex, multifaceted behaviour that is physical activity [13].

In conclusion, for adults with CF achieving physical activity guidelines by undertaking multiple bouts of MVPA ≥10 min duration in a day, but not shorter periods of physical activity, was independently associated with less decline in FEV1 over 3 years. Understanding the pattern by which adults with CF undertake physical activity, and its effect on clinical outcomes, may enhance our ability to develop realistic and achievable interventions that promote meaningful physical activity participation in this population.

Footnotes

  • Conflict of interest: None declared.

  • Support statement: N.S. Cox is a recipient of a National Health and Medical Research Council (NHMRC) Early Career Fellowship (GNT 1119970) and previously held an NHMRC postgraduate scholarship (GNT 602550) and a Cystic Fibrosis Australia PhD stipend.

  • Data from this manuscript have been presented at the Canadian Respiratory Society Conference, April 14–16, 2016, Halifax, Nova Scotia; and at the American Thoracic Society International Conference, May 13–18, 2016, San Francisco, California.

  • Received July 31, 2017.
  • Accepted January 26, 2018.
  • Copyright ©ERS 2018

This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Nixon P,
    2. Orenstein D,
    3. Kelsey S, et al.
    The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992; 327: 1785–1788.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Schneiderman JE,
    2. Wilkes DL,
    3. Atenafu EG, et al.
    Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis. Eur Respir J 2014; 43: 817–823.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    WHO. Global recommendations for physical activity and health. Geneva, WHO Press, 2010.
  4. ↵
    1. White D,
    2. Stiller K,
    3. Haensel N
    . Adherence of adult cystic fibrosis patients with airway clearance and exercise regimens. J Cyst Fibros 2007; 6: 163–170.
    OpenUrlPubMed
  5. ↵
    1. Cox N,
    2. Alison JA,
    3. Holland AE
    . Interventions for promoting physical activity in people with cystic fibrosis. Cochrane Database Syst Rev 2013; 12: CD009448.
    OpenUrlPubMed
  6. ↵
    1. Haskell W,
    2. Lee I-M,
    3. Pate RR, et al.
    Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39: 1423–1434.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Cox NS,
    2. Alison JA,
    3. Button BM, et al.
    Physical activity participation by adults with cystic fibrosis: an observational study. Respirology 2016; 21: 511–518.
    OpenUrl
  8. ↵
    1. Murphy MH,
    2. Nevill AM,
    3. Neville C, et al.
    Accumulating brisk walking for fitness, cardiovascular risk, and psychological health. Med Sci Sports Exerc 2002; 34: 1468–1474.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Savi D,
    2. Simmonds N,
    3. Di Paolo M, et al.
    Relationship between pulmonary exacerbations and daily physical activity in adults with cystic fibrosis. BMC Pulm Med 2015; 15: 151.
    OpenUrl
  10. ↵
    1. Ainsworth BE,
    2. Haskell W,
    3. Herrmann S, et al.
    2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc August 2011; 43: 1575–1581.
    OpenUrl
  11. ↵
    1. Collaco JM,
    2. Blackman SM,
    3. Raraigh KS, et al.
    Self-reported exercise and longitudinal outcomes in cystic fibrosis: a retrospective cohort study. BMC Pulm Med 2014; 14: 159.
    OpenUrl
  12. ↵
    1. Cox NS,
    2. Alison JA,
    3. Button BM, et al.
    Validation of a multi-sensor armband during free-living activity in adults with cystic fibrosis. J Cyst Fibros 2014; 13: 347–350.
    OpenUrl
  13. ↵
    1. Warren JM,
    2. Ekelund U,
    3. Besson H, et al.
    Assessment of physical activity – a review of methodologies with reference to epidemiological research: a report of the exercise physiology section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2010; 17: 127–139.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Bradley J,
    2. O'Neill B,
    3. Kent L, et al.
    Physical activity assessment in cystic fibrosis: a position statement. J Cyst Fibros 2015; 14: e25–e32.
    OpenUrl
  15. ↵
    1. Waschki B,
    2. Spruit MA,
    3. Watz H, et al.
    Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 2012; 106: 522–530.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Vol 4 Issue 2 Table of Contents
ERJ Open Research: 4 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Accumulating physical activity in at least 10-minute bouts predicts better lung function after 3-years in adults with cystic fibrosis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Accumulating physical activity in at least 10-minute bouts predicts better lung function after 3-years in adults with cystic fibrosis
Narelle S. Cox, Jennifer A. Alison, Brenda M. Button, John W. Wilson, Judith M. Morton, Anne E. Holland
ERJ Open Research Apr 2018, 4 (2) 00095-2017; DOI: 10.1183/23120541.00095-2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Accumulating physical activity in at least 10-minute bouts predicts better lung function after 3-years in adults with cystic fibrosis
Narelle S. Cox, Jennifer A. Alison, Brenda M. Button, John W. Wilson, Judith M. Morton, Anne E. Holland
ERJ Open Research Apr 2018, 4 (2) 00095-2017; DOI: 10.1183/23120541.00095-2017
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • CF and non-CF bronchiectasis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Unstable control of breathing can lead to ineffective NIV
  • Desmosine as a biomarker of azithromycin treatment response
  • Hypersensitivity pneumonitis in fish processing workers
Show more Original research letter

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society